These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11309288)
1. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women? Ursin G; Wilson M; Henderson BE; Kolonel LN; Monroe K; Lee HP; Seow A; Yu MC; Stanczyk FZ; Gentzschein E Cancer Res; 2001 Apr; 61(8):3326-9. PubMed ID: 11309288 [TBL] [Abstract][Full Text] [Related]
2. Urinary estrogen metabolites and their ratio among Asian American women. Falk RT; Fears TR; Xu X; Hoover RN; Pike MC; Wu AH; Nomura AM; Kolonel LN; West DW; Sepkovic DW; Bradlow HL; Ziegler RG Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):221-6. PubMed ID: 15668498 [TBL] [Abstract][Full Text] [Related]
3. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002 [TBL] [Abstract][Full Text] [Related]
4. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704 [TBL] [Abstract][Full Text] [Related]
5. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Jernström H; Klug TL; Sepkovic DW; Bradlow HL; Narod SA Carcinogenesis; 2003 May; 24(5):991-1005. PubMed ID: 12771045 [TBL] [Abstract][Full Text] [Related]
6. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724 [TBL] [Abstract][Full Text] [Related]
7. Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women. Moore SC; Matthews CE; Ou Shu X; Yu K; Gail MH; Xu X; Ji BT; Chow WH; Cai Q; Li H; Yang G; Ruggieri D; Boyd-Morin J; Rothman N; Hoover RN; Gao YT; Zheng W; Ziegler RG J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27193440 [TBL] [Abstract][Full Text] [Related]
8. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats. Lotinun S; Westerlind KC; Turner RT J Endocrinol; 2001 Jul; 170(1):165-74. PubMed ID: 11431149 [TBL] [Abstract][Full Text] [Related]
9. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer. Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246 [TBL] [Abstract][Full Text] [Related]
10. Estrogen metabolites and systolic blood pressure in a population-based sample of postmenopausal women. Masi CM; Hawkley LC; Berry JD; Cacioppo JT J Clin Endocrinol Metab; 2006 Mar; 91(3):1015-20. PubMed ID: 16384842 [TBL] [Abstract][Full Text] [Related]
11. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970 [TBL] [Abstract][Full Text] [Related]
12. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Eliassen AH; Spiegelman D; Xu X; Keefer LK; Veenstra TD; Barbieri RL; Willett WC; Hankinson SE; Ziegler RG Cancer Res; 2012 Feb; 72(3):696-706. PubMed ID: 22144471 [TBL] [Abstract][Full Text] [Related]
13. Estrogen profiles in young women: effect of maternal history of breast cancer. Morgan RW; Vakil DV; Brown JB; Elinson L J Natl Cancer Inst; 1978 May; 60(5):965-7. PubMed ID: 642038 [TBL] [Abstract][Full Text] [Related]
14. Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women. Napoli N; Vattikuti S; Yarramaneni J; Giri TK; Nekkalapu S; Qualls C; Armamento-Villareal RC Maturitas; 2012 May; 72(1):66-71. PubMed ID: 22385932 [TBL] [Abstract][Full Text] [Related]
15. The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. Maskarinec G; Heak S; Morimoto Y; Custer L; Franke AA Cancer Epidemiol; 2012 Oct; 36(5):e310-6. PubMed ID: 22537763 [TBL] [Abstract][Full Text] [Related]
16. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data. Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302 [TBL] [Abstract][Full Text] [Related]
17. The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA. Trichopoulos D; Yen S; Brown J; Cole P; MacMahon B Cancer; 1984 Jan; 53(1):187-92. PubMed ID: 6690000 [TBL] [Abstract][Full Text] [Related]
18. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial. Mackey RH; Fanelli TJ; Modugno F; Cauley JA; McTigue KM; Brooks MM; Chlebowski RT; Manson JE; Klug TL; Kip KE; Curb JD; Kuller LH Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2022-32. PubMed ID: 22933427 [TBL] [Abstract][Full Text] [Related]
19. [Study on metabolic pathway from dehydroepiandrosterone sulfate to estrogen in late pregnancy (author's transl)]. Ichimaru S Nihon Naibunpi Gakkai Zasshi; 1975 Sep; 51(9):693-704. PubMed ID: 133827 [TBL] [Abstract][Full Text] [Related]
20. The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support. Stanczyk FZ J Steroid Biochem Mol Biol; 2020 Jul; 201():105685. PubMed ID: 32320758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]